Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $256,209 | 117 | 48.6% |
| Consulting Fee | $119,185 | 66 | 22.6% |
| Honoraria | $83,230 | 35 | 15.8% |
| Travel and Lodging | $34,930 | 148 | 6.6% |
| Food and Beverage | $23,269 | 723 | 4.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $10,450 | 10 | 2.0% |
| Education | $93.71 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $108,295 | 147 | $0 (2024) |
| Lundbeck LLC | $103,282 | 122 | $0 (2021) |
| Abbott Laboratories | $80,682 | 209 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $56,236 | 43 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $45,529 | 111 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $41,168 | 93 | $0 (2024) |
| PFIZER INC. | $23,399 | 53 | $0 (2023) |
| ARALEZ PHARMACEUTICALS US INC. | $21,096 | 27 | $0 (2018) |
| Medtronic Vascular, Inc. | $16,573 | 72 | $0 (2020) |
| Philips Electronics North America Corporation | $15,574 | 26 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,953 | 72 | Janssen Pharmaceuticals, Inc ($8,856) |
| 2023 | $20,503 | 68 | Abbott Laboratories ($11,799) |
| 2022 | $36,768 | 73 | SANOFI-AVENTIS U.S. LLC ($17,832) |
| 2021 | $57,223 | 129 | SANOFI-AVENTIS U.S. LLC ($25,371) |
| 2020 | $72,442 | 94 | Lundbeck LLC ($18,557) |
| 2019 | $112,838 | 193 | Janssen Pharmaceuticals, Inc ($43,467) |
| 2018 | $116,410 | 242 | Abbott Laboratories ($37,827) |
| 2017 | $99,230 | 230 | Lundbeck LLC ($20,201) |
All Payment Transactions
1,101 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.16 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.10 | General |
| Category: Cardiovascular | ||||||
| 11/04/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Endocrinology | ||||||
| 10/25/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $605.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| Category: Cardiovascular | ||||||
| 09/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: Obesity | ||||||
| 09/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: General - Tachy_CRM | ||||||
| 09/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Cardiology | ||||||
| 09/09/2024 | Abbott Laboratories | ENSITE (Device) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Electrophysiology | ||||||
| 08/30/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $239.57 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/30/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $75.50 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: Cardiovascular | ||||||
| 08/22/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $345.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/22/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $237.85 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/22/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $171.65 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 4,090 | 6,506 | $1.1M | $422,263 |
| 2022 | 53 | 3,569 | 4,988 | $919,102 | $355,388 |
| 2021 | 48 | 5,383 | 9,497 | $1.2M | $492,462 |
| 2020 | 48 | 5,269 | 11,052 | $1.3M | $524,503 |
All Medicare Procedures & Services
202 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 314 | 514 | $186,068 | $73,812 | 39.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 177 | 189 | $83,160 | $30,658 | 36.9% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 35 | 36 | $79,380 | $29,530 | 37.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 77 | 77 | $72,611 | $28,901 | 39.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 76 | 77 | $22,800 | $17,572 | 77.1% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 38 | 38 | $39,520 | $16,983 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 127 | 151 | $39,362 | $14,737 | 37.4% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 18 | 18 | $32,562 | $14,014 | 43.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 55 | 132 | $26,136 | $13,231 | 50.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 112 | 199 | $22,288 | $13,230 | 59.4% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 31 | 48 | $39,696 | $12,732 | 32.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 63 | 353 | $52,950 | $11,270 | 21.3% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 16 | 16 | $26,464 | $11,218 | 42.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 56 | 56 | $22,064 | $9,867 | 44.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 220 | 511 | $26,061 | $9,630 | 37.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 412 | 752 | $41,360 | $9,131 | 22.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 140 | 313 | $20,345 | $7,519 | 37.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,013 | 1,146 | $19,482 | $7,498 | 38.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 62 | 353 | $18,003 | $7,458 | 41.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 51 | $19,686 | $7,348 | 37.3% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 83 | 200 | $25,800 | $5,580 | 21.6% |
| 33225 | Insertion of left lower heart electrode for pacemaker or defibrillator | Facility | 2023 | 14 | 14 | $12,782 | $5,532 | 43.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 38 | 63 | $10,899 | $5,491 | 50.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 31 | 121 | $10,648 | $5,264 | 49.4% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 73 | 114 | $6,840 | $4,434 | 64.8% |
About Dr. Sean Beinart, M.D
Dr. Sean Beinart, M.D is a Internal Medicine healthcare provider based in Rockville, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083714661.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Beinart, M.D has received a total of $527,366 in payments from pharmaceutical and medical device companies, with $11,953 received in 2024. These payments were reported across 1,101 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($256,209).
As a Medicare-enrolled provider, Beinart has provided services to 18,311 Medicare beneficiaries, totaling 32,043 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 202 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Clinical Cardiac Electrophysiology
- Location Rockville, MD
- Active Since 09/24/2006
- Last Updated 05/20/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083714661
Products in Payments
- XARELTO (Drug) $108,358
- NORTHERA (Drug) $103,282
- ELIQUIS (Drug) $68,715
- MULTAQ (Drug) $41,439
- LifeVest (Device) $41,168
- Confirm Rx (Device) $13,972
- Ensite Cardiac Mapping System (Device) $13,746
- CVX-300 (Device) $13,678
- Merlin Connectivity and Remote (Device) $12,345
- ZONTIVITY (Drug) $11,683
- YOSPRALA (Drug) $9,413
- Savaysa (Drug) $6,314
- ADVISOR (Device) $6,050
- Connectivity and Remote care (Device) $6,038
- ENSITE (Device) $5,829
- EnSite Precision Cardiac Mapping System (Device) $5,150
- ViewMate Intracardiac Echo (Device) $4,188
- AVEIR (Device) $3,355
- Reveal LINQ (Device) $3,128
- Veltassa (Drug) $2,858
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rockville
Dr. Matthew Mintz, M.d, M.D
Internal Medicine — Payments: $182,708
Gerti Tashko, M.d, M.D
Internal Medicine — Payments: $134,518
Dr. Amy Compton Phillips, Md, MD
Internal Medicine — Payments: $17,390
Dr. Shishir Khetan, Md, MD
Internal Medicine — Payments: $16,690
Leo Shue, Md, MD
Internal Medicine — Payments: $14,289
Dr. Ajay Reddy, M.d, M.D
Internal Medicine — Payments: $14,070